Media & Investor Relations:
Troy Wichterman
Chief Financial Officer
(425) 402 - 1400
twichterman@biolifesolutions.com
Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, New York 11717
USA
(877) 830 - 4936
shareholder@broadridge.com
Register here to receive email notifications with updates about our press releases, stock price, SEC filings and more.
Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email link below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
- Jun 25 2013CryoStor® and HypoThermosol® Enable Improved Stability and Expanded Distribution of Blood Derived Cells for Research and Clinical Use
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Jun 24 2013Award Based on Benefits, Team Member Surveys, Growth, Corporate Culture
BioLife Solutions, Inc. (OTC:BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- May 23 2013Presentation to Outline Risks in Using Non-Optimized Storage, Transport & Cryopreservation Media with Clinical Cell- and Tissue-Based Therapies
BioLife Solutions, Inc. (OTC:BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- May 14 2013Company Achieves Operating Income of $0.2 Million Driven by Organic Growth, Licensing Revenue
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- May 06 2013Continued Adoption of CryoStor® and HypoThermosol® in Clinical Applications
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- May 06 2013Continued Adoption of CryoStor® and HypoThermosol® in Clinical Applications
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- May 02 2013Custom Formulation of CryoStor® Cell Freeze Media Used in Clinical Trial of Cell Therapy
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Apr 01 2013Company Generated Positive Cash Flow From Operations in 2012
BOTHELL, WA— April 1, 2013 —BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze...
- Feb 04 2013CEO of Kirkland, WA-Based Cardiac Dimensions, Inc.
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Jan 08 2013
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Jan 07 2013Sales to All Strategic Market Segments up over 2011; Company Generated Positive Cash Flow From Operations in 2012
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Jan 02 2013
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Dec 12 2012HypoThermosol Utilized as Combination Biopreservation Medium and Vehicle Solution for Therapeutic Cells
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Nov 13 2012135% Year-over-Year Growth in Third Quarter Revenues; 2012 Full Year Revenue Guidance Increased to $5.0 Million
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Oct 29 2012Company's Novel Biopreservation Technology Recognized as Leading Choice For Commercialization In Emerging Field of Regenerative Medicine
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Oct 17 2012Combination of Cellenergy and BioLife's HypoThermosol® Storage and Shipping Media Demonstrates Improved Storage of Hair Grafts
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Sep 12 2012Company Estimates more than 60% of Attending Companies Are Customers
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Aug 14 20122012 Revenue Guidance Reiterated at $4.1 Million
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Jul 23 2012Company Hiring to Support Increased Demand for Biopreservation Media Products, Contract Manufacturing Services
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Jul 09 2012Sales of Proprietary Products and Contract Manufacturing Revenue Drive 31% Sequential, 76% Year-Over-Year Growth
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Jun 01 2012Addendum Provides Financial Flexibility as Revenue Ramps
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- May 14 2012Gross Margin Increase; Facility Expansion Underway to Support New Manufacturing Agreement; Guidance of 50% Annual Revenue Growth
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Mar 26 2012Management Forecasts Revenue Growth of at Least 50% and Positive Cash Flow
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and...
- Mar 12 2012HypoThermosol® and CryoStor® Will Be Locally Available to the Broader European Research and Clinical Markets
PRLog (Press Release) – Mar 12, 2012 – tebu-bio, a leading distributor of reagents to the European research and clinical communities, today announced that it has executed a distribution...
- Mar 05 2012Demand for HypoThermosol® and CryoStor®, and New Contract Manufacturing Agreement Driving Growth and Creation of New Jobs
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues,...
- Feb 17 2012
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues,...
- Feb 06 2012Therapeutic Cells Are Frozen in CryoStor® GMP Cryopreservation Media, Shipped to the Clinic, Thawed and Injected into Cancer Patients
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues,...
- Jan 27 2012BioLife Solutions Biopreservation Media Products Outperform Traditional, Non-Optimized Formulations
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer, and marketer of proprietary hypothermic storage and cryopreservation freeze media for cells and tissues, today announced...
- Jan 23 2012New Members Include Key Opinion Leaders in Biobanking, Drug Discovery, and Regenerative Medicine Markets
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer, and marketer of proprietary hypothermic storage and cryopreservation freeze media for cells, tissues, and organs, today...
- Jan 10 2012Sixth Straight Quarter of Record Revenue
BioLife Solutions Inc. (OTCBB: BLFS), a leading developer, manufacturer, and marketer of proprietary hypothermic storage and cryopreservation freeze media for cells and tissues, today announced...
- Dec 06 2011Promotion Designed to Drive Adoption of CryoStor® and HypoThermosol® in the Biobanking, Drug Discovery, and Regenerative Medicine Markets
BioLife Solutions Inc. (OTCBB: BLFS), a leading developer, manufacturer, and marketer of proprietary biopreservation media products for cells, tissues, and organs, today announced the launch of...
- Oct 03 2011More than 300 Direct and Indirect Customers Now Providing Solid Growth Foundation
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer and manufacturer of clinical grade biopreservation media products for cells and tissues and contract media manufacturer, today announced...
- Jul 06 2011Strong Sales to Strategic Market Segments Including Drug Discovery, Biobanking, and Regenerative Medicine
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer and manufacturer of clinical grade biopreservation media products for cells and tissues, today announced preliminary revenue of $623,000...
- Jun 21 2011Key Customers Using CryoStor® and BloodStor® Include Community Blood Services, China Cord Blood Bank, and ViaCord
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer and manufacturer of clinical grade biopreservation media products for cells and tissues, today announced that it has become the leading...
- Jun 01 2011HypoThermosol® and CryoStor® Now Incorporated into the Development Stage Products of Hundreds of High Profile Organizations
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer and manufacturer of clinical grade biopreservation media products for cells and tissues, today issued an update on the growing number and...
- Apr 06 2011Distributor Sales More Than 50% of 2010 Total
BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer and manufacturer of clinical grade biopreservation media products for cells and tissues, today announced preliminary revenue of $611,000...
- Jan 18 2011
BioLife Solutions, Inc. (OTC Bulletin Board: BLFS) announced today that it has significantly increased its financial support for several key organizations in the regenerative medicine industry....
- Jan 10 2011
BioLife Solutions, Inc. (OTC Bulletin Board: BLFS) is issuing the following corporate update today by its Chairman and Chief Executive Officer Mike Rice, to summarize the continued progress the...
- May 20 2010
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , announced today that Chairman and Chief Executive Officer Mike Rice issued the following letter to shareholders providing a general corporate...
- Jan 21 2010Distribution and Contract Manufacturing Agreements Executed to Support Strategic Relationship and Increased Adoption of Complementary Products
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, and OriGen Biomedical, a leading provider...
- Dec 23 2009Product Adoption Growing in Clinical Cell Therapy & Regenerative Medicine Markets
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, today announced that it has successfully...
- Dec 07 2009Variant of CryoStor DLite® Biopreservation Media Used in Cell Therapy Product Development
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, today announced that it has executed a...
- Nov 18 2009Key Intellectual Property Related to Minimizing Biopreservation-Induced Cell Death
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , a leading developer, manufacturer, and marketer of proprietary cGMP hypothermic storage and cryopreservation media products for cells, tissues, and...
- Sep 14 2009
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, today announced that Sigma-Aldrich will...
- Aug 31 2009Industry Standard Product Should Drive Increased Revenue From Cord Blood Banks
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, today announced the launch of its...
- Aug 17 2009Deal Expands Access to Best-in-Class HypoThermosol® and CryoStor™ Biopreservation Media Products via Sub-Distributor Network in Over 70 Countries
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , a leading manufacturer and marketer of biopreservation tools for cells, tissues, and organs, today announced that it has entered into a...
- Jun 09 2009Quality System and Facility Support Increased Capacity, Cost Reductions, Custom Packaging, Regulatory Filings
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , a leading biopreservation tools provider, today announced that it has completed the construction and validation of its internal GMP manufacturing...
- Apr 13 2009Decision Based on Improved Recovery and Elimination of Serum in Cryopreservation of Cell Lines Used in Worldwide Disease Research Efforts
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , a leading developer and marketer of proprietary cGMP hypothermic storage and cryopreservation media products for cells, tissues, and organs, today...
- Mar 10 2009Independent, Comparative Evaluation by Leading Research Centers in Germany and Portugal Indicates Significant Biopreservation Advantages of Serum-Free, Pre-Formulated CryoStor
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , a leading developer and marketer of proprietary cGMP hypothermic storage and cryopreservation media products for cells, tissue, and organs, today...
- Jan 26 2009Publication Solely Dedicated to Advancing the Biopreservation Field
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , a leading developer and marketer of proprietary GMP hypothermic storage and cryopreservation media products for cells, tissues, and organs, today...
- Jan 26 2009Internal Manufacturing Scale-Up Underway to Support Increased Product Demand
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , a leading developer and marketer of proprietary GMP hypothermic storage and cryopreservation media products for cells, tissues, and organs, today...
- Dec 29 2008Potential Collaborative Research to Focus on Scientific Advancements in Preservation of Transfusion Related Biologics
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , a leading developer and marketer of proprietary cGMP hypothermic storage and cryopreservation media products for cells, tissues, and organs, today...
- Dec 16 2008Additional Safety Data Could Drive Product Adoption in High-Growth Cell Therapy Market
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , a leading developer and marketer of proprietary cGMP hypothermic storage and cryopreservation media products for cells, tissues, and organs, today...
- Dec 08 2008Expands Protection of Key Intellectual Property Related to Minimizing Cell Death
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , a leading developer and marketer of proprietary cGMP hypothermic storage and cryopreservation media products for cells, tissues, and organs, today...
- Nov 14 2008Product Development Will Benefit From Input of Physician in Strategic Cell Therapy Market
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells, tissues, and organs, today...
- Nov 05 2008Materials, Components and Manufacturing Process Documentation for Customer Clinical Applications
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) , a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells, tissues, and organs, today...
- Nov 04 2008Cord Blood Bank Sees Significant Benefits from Next-Generation Biopreservative Product
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells, tissues, and organs, today...
- Oct 24 2008Preservation with BioLife's Proprietary, Next Generation, Biopreservation Media Resulted in Increased Yield and Quality of Insulin-Producing Islet Cells
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) , a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells, tissues, and organs, today...
- Oct 21 2008Access to Additional Capital Will Enable Revenue Growth
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) , a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells, tissues, and organs, today...
- May 08 2008
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) , a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells, tissues, and organs, today...
- Mar 27 2008Oncolix, Inc. Selects CryoStor for Cryopreservation of Cell-Based Melanoma Therapy
BOTHELL, WA. – March 27, 2008 – BioLife Solutions Inc. (OTC BB: BLFS), a leading developer and marketer of proprietary hypothermic storage and freeze media products for cells, tissues, and...
- Mar 27 2008Oncolix, Inc. Selects CryoStor™ for Cryopreservation of Cell-Based Melanoma Therapy
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) , a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells, tissues, and organs, today...
- Oct 29 2007Strategy to Focus on Sales Growth and Product Development
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) , a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells, tissues, and organs, today...
- Sep 17 2007Umbilical Cord Tissue Provides Building-Block Cells for Muscle, Bone, Connective Tissues
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) , a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells, tissues, and organs, today...
- Sep 05 2007Adds Cell Therapy Regulatory Consultant and Cryopreservation Expert
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells, tissues, and organs, today...
- Aug 17 2007Significant Improvement in Number and Viability of Stem Cells Derived from Cord Blood Enabled by BioLife's Patented Preservation Media
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) , a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells, tissues, and organs, today...
- Jun 26 2007Storage and Preservation Media Critical for Manufacturing Cellular Therapy Products
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) , a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells, tissues, and organs today...
- Jun 25 2007Independent Study Indicates 20-50% Improvement in Post-Preservation Functional Recovery of Peripheral Blood Stem Cells for Cancer Therapy
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) , a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells, tissues, and organs, today...
- May 08 2007
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) , a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells, tissues, and organs, today...
- May 07 2007Storage and Preservation Media Critical for Manufacturing of Cellular Therapy Products
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) , a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells and tissues, today announced a...
- Apr 30 2007Move to Seattle-Area Biotech Hub Improves Customer Service, Access to Researchers
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) , a leading developer and manufacturer of proprietary liquid preservation media for cells, tissues, and organs, today announced it completed the...
- Apr 25 2007
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) a leading manufacturer of proprietary preservation media products for cells and tissues, announced today that it has granted a product license to...
- Apr 05 200741% Sales Growth Driven by Increasing Product Adoption in Cell Therapy Market
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) , a leading developer and manufacturer of proprietary preservation media for cells, tissues, and organs, today announced preliminary sales for...
- Feb 16 2007Life Sciences Products Distributor to Market, Distribute BioLife's Proprietary Biologics Preservation Media to Japanese Biotech Industry
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) , a leading developer and manufacturer of proprietary preservation media for cells, tissues, and organs, today announced it appointed Funakoshi Co.,...
- Feb 14 2007Expertise in Cell Therapy to Aid Research and Marketing Strategies
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) , a leading developer and manufacturer of proprietary preservation media for cells, tissues, and organs, today announced the appointment of Andrew G....
- Feb 13 2007Proceeds to Support Expanded Sales & Marketing Strategy
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) , a leading developer and manufacturer of proprietary preservation media for cells, tissues, and organs, today announced the completion of a $750,000...
- Jan 23 2007Also Announces Strategic Management Changes
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) a leading manufacturer of proprietary cryopreservation media for cells and tissues, today announced preliminary results for product sales for the...
- Oct 31 2006CORNING® CELLBIND® SURFACE USED WITH BIOLIFE SOLUTIONS’ CRYOSTOR OFFERS 58-PERCENT INCREASE IN 24-HOUR POST-PRESERVATION CELL SURVIVAL
OWEGO, NY. – Oct. 31, 2006 – BioLife Solutions Inc. (OTC BB: BLFS), a leading developer and marketer of proprietaryhypothermic storage and freeze media products for cells, tissues, and organs...
- Oct 04 2006Leading Cancer Therapy Researcher, Cryopreservation Researcher, and Regulatory Expert Join as Founding Outside Members
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) , a leading marketer of proprietary, serum and protein free hypothermic storage and cryopreservation solutions for cells and tissue at low...
- Jul 27 2006Twenty Year Med-Tech Executive to Lead Company in Emerging Market for Cryopreservation Technologies
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) , a developer, manufacturer, and marketer of proprietary cryopreservation solutions for cells and tissue storage and preservation at low temperatures,...
- May 17 2006
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , a leading manufacturer and marketer of cryopreservation solutions for the preservation of cells and tissues at low temperatures, announced today...
- May 16 2006Stem Cells' Ability to Grow and Transform Into New Cells/Tissues Improved 67% With BioLife Product
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) , a leading manufacturer and marketer of cryopreservation solutions for the preservation of cells and tissues at low temperatures, announced today...
- Aug 15 2005
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) announced today that it was granted a U.S. patent that covers the methods and compositions for the preservation of cells, tissues or organs in the...
- May 18 2005Orders to Commence in Second Quarter
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) announced today that it has entered into an exclusive manufacturing and distribution agreement with VWR International, a leader in the global research...
- Mar 04 2004
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) announced today the settlement of a dispute between the Company and Irvine, CA-based Endocare, Inc. , arising out of Endocare's failure to register...
- Dec 03 2003$1.38 Million in Financing; $177,000 from NIH; $1.6 Million Awarded in Court Decision
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) announced today that it has secured $1.381 million through the sale in a private placement to investors, of Units consisting of Series G Convertible...
- Mar 03 2003
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) announced today that it has signed a multi-year research and development agreement with Edison, NJ-based Tissue Transformation Technologies...
- Feb 18 2003
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) announced today that it has reached a key milestone in its strategy to begin positioning the Company for future sales growth with the signing of a...
- Jan 22 2003New Preservation Solution Promises to Speed Development of Pioneering Cell and Tissue Engineering Therapies
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) announced today that data from a new study demonstrates that the Company's Hypothermosol® family of preservation solutions significantly extends the...
- Nov 15 2002
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) announced today results for its third quarter and nine months ended September 30, 2002, the first full quarter of operation since the divesture of...
- Nov 07 2002
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) announced today that President and CEO John Baust, Ph.D., is scheduled to make an investor presentation at the Wall Street Analyst Forum's 46th...
- Oct 22 2002
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) announced today that President and CEO John Baust, Ph.D., is scheduled to make an investor presentation at TechVest's 4th Annual Healthcare...
- Oct 21 2002
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) announced today that it has selected Irvine, CA-based Allen & Caron Inc, a full-service investor and media relations firm, to support its investor,...
- Oct 16 2002
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) announced that the National Institutes of Health (NIH) has awarded the Company a grant of $158,000 under the NIH's Small Business Innovation Research...
- Sep 30 2002Reflects Company's Focus as Developer and Marketer of Cell Preservation Technology to Biotechnology Industry
Cryomedical Sciences, Inc. (BULLETIN BOARD: BLFS) announced that effective September 30, 2002, the Company has changed its name to BioLife Solutions, Inc. and will begin to trade under the new...
- Jun 27 2002Board Approves Name Change to BioLife Solutions, Inc., New CEO And New Strategic Focus
Cryomedical Sciences, Inc. (BULLETIN BOARD: CRYM) (CMS) announced today that it has completed the sale of its cryosurgery product line and related intellectual property assets to Irvine, CA-based...
- May 29 2002Announces New CEO, Proposed Name Change and New Strategic Focus on Proprietary Cell and Tissue Preservation Products
Cryomedical Sciences, Inc. (BULLETIN BOARD: CRYM) (CMS) announced that it has executed a definitive agreement to sell its cryosurgical product line and related intellectual property assets to...